Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
Tsujimoto T, Sugiyama T, Shapiro MF, et al.
Hypertension. 2017;70:103-10
Leggi
Breaking news
Hospitalization for Charcot neuroarthropathy in diabetes: A population study in Italy.
Anichini R, Policardo L, Lombardo FL, Salutini E, Tedeschi A, Viti S, Francia P, Brocco E, Maggini M, Seghieri G, De Bellis A
Diabetes Res Clin Pract. 2017,129:25–31
Leggi
Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients
Mazidi M, Rezaie P, Gao H-K, et al.
J Am Heart Assoc. 2017;6:e004007
Leggi
Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure
Benotti PN, Wood GC, Carey DJ, et al.
J Am Heart Assoc. 2017;6:e005126
Leggi
Clinical Use of Professional Continuous Glucose Monitoring
Wright Jr EE, Gavin III JR
Diabetes Technology & Therapeutics. 2017:19(S2):S12-5
Leggi
Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes
Slattery D, Choudhary P
Diabetes Technology & Therapeutics. 2017:19(S2):S55-61
Leggi
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan RA
Diabetes Technology & Therapeutics. 2017:19(S2):S27-36.
Leggi
Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson AL, Mullen DM and Bergenstal RM
Diabetes Technology & Therapeutics. 2017:19(S2):S4-11.
Leggi
Flash Glucose Monitoring: The Future Is Here
Garg SK, Akturk HK
Diabetes Technology & Therapeutics. 2017:19(S2):S1-3
Leggi
Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration
Fernandez-Mendoza J, He F, LaGrotte C,et al.
J Am Heart Assoc. Pub. online May 17, 2017
Leggi